title: Nutritional status and the gonadotrophic response to a polar expedition.
abstract: Polar expeditions have been associated with changes in the hypothalamic-pituitary-testicular axis consistent with central hypogonadism (i.e., decreased testosterone, luteinising hormone (LH), and follicle stimulating hormone (FSH)). These changes are typically associated with body mass loss. Our aim was to evaluate whether maintenance of body mass during a polar expedition could mitigate against the development of central hypogonadism. Male participants (n = 22) from a 42-day expedition (British Services Antarctic Expedition 2012) volunteered to take part in the study. Body mass, body composition, and strength data were recorded pre- and postexpedition in addition to assessment of serum testosterone, LH, FSH, thyroid hormones, insulin-like growth factor 1 (IGF-1), and trace elements. Energy provision and energy expenditure were assessed at mid- and end-expedition. Daily energy provision was 6335 ± 149 kcal·day(-1). Estimated energy expenditure midexpedition was 5783 ± 1690 kcal·day(-1). Body mass and percentage body fat did not change between pre- and postexpedition. Total testosterone (nmol·L(-1)) (14.0 ± 4.9 vs. 17.3 ± 4.0, p = 0.006), calculated free testosterone (pmol·L(-1)) (288 ± 82 vs. 350 ± 70, p = 0.003), and sex hormone binding globulin (nmol·L(-1)) (33 ± 12 vs. 36 ± 11, p = 0.023) concentrations increased. LH and FSH remained unchanged. Thyroid stimulating hormone (TSH; IU·L(-1)) (2.1 ± 0.8 vs. 4.1 ± 2.1, p < 0.001) and free triiodothyronine (FT3; IU·L(-1)) (5.4 ± 0.4 vs. 6.1 ± 0.8, p < 0.001) increased while free thyroxine, IGF-1, and trace elements remained unchanged. Hand-grip strength was reduced postexpedition but static lift strength was maintained. Maintenance of body mass and nutritional status appeared to negate the central hypogonadism previously reported from polar expeditions. The elevated TSH and free FT3 were consistent with a previously reported "polar T3 syndrome".
authors.forename: David R
authors.initials: DR
authors.lastname: Woods
authors.forename: Simon K
authors.initials: SK
authors.lastname: Delves
authors.forename: Sophie E
authors.initials: SE
authors.lastname: Britland
authors.forename: Anneliese
authors.initials: A
authors.lastname: Shaw
authors.forename: Piete E
authors.initials: PE
authors.lastname: Brown
authors.forename: Conor
authors.initials: C
authors.lastname: Bentley
authors.forename: Simon
authors.initials: S
authors.lastname: Hornby
authors.forename: Anne
authors.initials: A
authors.lastname: Burnett
authors.forename: Sue A
authors.initials: SA
authors.lastname: Lanham-New
authors.forename: Joanne L
authors.initials: JL
authors.lastname: Fallowfield
mesh_terms: D000328:Adult; D000418:Albumins / Q000378:metabolism; D000864:Antarctic Regions; D001798:Blood Proteins; D002149:Energy Intake; D005504:Food Analysis; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status / Q000502:physiology*; D005082:Physical Exertion / Q000502:physiology*; D013739:Testosterone / Q000097:blood*; D013972:Thyrotropin / Q000097:blood*; D014284:Triiodothyronine / Q000097:blood*; D055815:Young Adult
chemical_list: D000418:Albumins; D001798:Blood Proteins; D014284:Triiodothyronine; D013739:Testosterone; D007334:Insulin-Like Growth Factor I; D013972:Thyrotropin